Michael W.Y. Chan
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 12
- MicroRNA in disease regulation 6
- Cancer, Lipids, and Metabolism 4
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 33
- Cancer-related gene regulation 17
- RNA modifications and cancer 15
- Histone Deacetylase Inhibitors Research 5
- Oncology top 10%
-
- Bladder and Urothelial Cancer Treatments 5
Michael W.Y. Chan
86 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 130
- Cancer Research 408
- Molecular Biology 1.2k
- Oncology 282
- Pulmonary and Respiratory Medicine 271
- Aging 14
Countries citing papers authored by Michael W.Y. Chan
This map shows the geographic impact of Michael W.Y. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W.Y. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W.Y. Chan more than expected).
Fields of papers citing papers by Michael W.Y. Chan
This network shows the impact of papers produced by Michael W.Y. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W.Y. Chan. The network helps show where Michael W.Y. Chan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael W.Y. Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 5 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 5 | |
| 10 | 2021 | 26 | |
| 11 | 2021 | 23 | |
| 12 | 2020 | 7 | |
| 13 | 2020 | 12 | |
| 14 | 2019 | 13 | |
| 15 | 2019 | 30 | |
| 16 | 2019 | 14 | |
| 17 | 2018 | 32 | |
| 18 | 2016 | 27 | |
| 19 | 2014 | 11 | |
| 20 | 2008 | 112 |
About Michael W.Y. Chan
Michael W.Y. Chan is a scholar working on Cancer Research, Molecular Biology and Otorhinolaryngology, having authored 92 papers that have together received 2.0k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (33 papers), Cancer-related gene regulation (17 papers), RNA modifications and cancer (15 papers), Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (6 papers), Histone Deacetylase Inhibitors Research (5 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Cancer, Lipids, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (408 citations), Molecular Biology (1.2k citations) and Oncology (282 citations). Michael W.Y. Chan has collaborated with scholars based in Taiwan, United States and Canada. Frequent co-authors include Kenneth P. Nephew, Pearlly S. Yan, Alfred S.L. Cheng, Ka‐Fai To, Tim H-M. Huang, Hung‐Cheng Lai, Rui Huang, Sandya Liyanarachchi, Juan Chen and Ramana V. Davuluri. Their work appears in journals such as Journal of the American Chemical Society, Molecular Cell and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.